Company Filing History:
1 out of 1,510 
1 out of 410 
Years Active: 2013
Title: Lapo Alinari: Innovator in Cancer Treatment
Introduction
Lapo Alinari is a notable inventor based in Dublin, OH (US). He has made significant contributions to the field of cancer treatment through his innovative research and patents. His work focuses on enhancing the effectiveness of therapies targeting cancer cells.
Latest Patents
Lapo Alinari holds a patent for a method involving FTY720, which increases CD74 expression and sensitizes cancer cells to anti-CD74 antibody-mediated cell death. The patent discloses methods and compositions that comprise fingolimod and anti-CD74 antibodies or fragments thereof. In preferred embodiments, fingolimod increases the expression of CD74 in target cells, enhancing their sensitivity to the cytotoxic effects of anti-CD74 antibodies. These compositions and methods are particularly useful in treating diseases involving CD74 cells, such as cancer, autoimmune diseases, or immune dysfunction diseases. He has 1 patent to his name.
Career Highlights
Throughout his career, Lapo Alinari has worked with esteemed institutions, including The Ohio State University and Immunomedics, Inc. His research has contributed to advancements in the understanding and treatment of cancer.
Collaborations
Lapo has collaborated with notable professionals in his field, including Robert A Baiocchi and Natarajan Muthusamy. Their combined expertise has furthered research efforts in cancer therapies.
Conclusion
Lapo Alinari's innovative work in cancer treatment exemplifies the impact of research and patents in advancing medical science. His contributions continue to influence the development of effective therapies for challenging diseases.